Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells

Journal of Immunology

Volumn 167, Issue 5, 2001, Pages 2921-2928

  Britigan, B E ^a   Lewis, T S ^a   Waldschmidt, M ^a   McCormick, M L ^a   Krieg, A M ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; DINUCLEOTIDE; IMMUNOSTIMULATING AGENT; IRON; LACTOFERRICIN B; LACTOFERRIN; OLIGODEOXYNUCLEOTIDE; OLIGONUCLEOTIDE; TRANSFERRIN;

ALLERGY; AMINO TERMINAL SEQUENCE; ARTICLE; ASTHMA; B LYMPHOCYTE; BACTERIAL INFECTION; CANCER; CONTROLLED STUDY; CPG ISLAND; DNA BINDING; DOWN REGULATION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; MUCOSA; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0035451425     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.5.2921     Document Type: Article

References (90)

1. CpG-rich islands and the function of DNA methylation
2. CpG motifs in bacterial DNA trigger direct B-cell activation
3. Immunostimulatory DNA sequences function as T-helper-1 promoting adjuvants
4. CpG oligodeoxynucleotides act as adjuvants that switch on T helper (Th1) immunity
5. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
6. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α
7. Oligonucleotides containing palindrome sequences with internal 5′-CpG-3′ act directly on human NK and activated T cells to induce IFN-γ production in vitro
8. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ
9. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria
10. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-γ-dependent mechanisms
11. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection
12. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge
13. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis
14. CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis
15. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma
16. Bacterial DNA or oligonucleotides containing unmethylated CpG motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway
17. Immunostimulatory DNA sequences inhibit IL-5 eosinophilic inflammation, and airway hyperresponsiveness in mice
18. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract
19. Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor
20. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization
21. Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides
22. Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides
23. Mechanism and function of a newly identified CpG DNA motif in human primary B cells
24. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by nonspecific endocytosis and endosomal maturation
25. A Toll-like receptor recognized bacterial DNA
26. Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88
27. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6
28. CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species
29. Studies on lactoferrin, an iron-binding protein common to many external secretions
30. Lactoferrin secretion into mouse milk: Development of secretory activity, the localization of lactoferrin in the secretory pathway, and interactions of lactoferrin with milk iron
31. Pathophysiology of rhinitis: Lactoferrin and lysozyme in nasal secretions
32. Character of azurophil and specific granules purified from human polymorphonuclear leukocytes
33. Association of lactoferrin with specific granules in rabbit heterophil leukocytes
34. Secretory responses of human neutrophils: Exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo
35. Correlation of lactoferrin with neutrophilic inflammation in body fluids
36. The development of awareness of iron-withholding defense
37. Role of iron in microbe-host interactions
38. Stimulated neutrophils limit iron-catalyzed hydroxyl radical formation as detected by spin trapping techniques
39. Lactoferrin-catalyzed hydroxyl radical production: Additional requirements for a chelating agent
40. The effect of human serum transferrin and milk lactoferrin on hydroxyl radical formation from superoxide and hydrogen peroxide
41. Killing of Gram-negative bacteria by lactoferrin and lysozyme
42. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin
43. A bactericidal effect for human lactoferrin
44. Role of cell-binding in the antibacterial mechanism of lactoferricin B
45. Identification of the bactericidal domain of lactoferrin
46. The biology of transferrin
47. 5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA
48. Lactoferrin-lipopolysaccharide interaction: Involvement of the 24-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide
49. Interaction of lactoferrin and lipopolysaccharide (LPS): Effects on the antioxidant property of lactoferrin and the ability of LPS to prime human neutrophils for enhanced superoxide formation
50. Lactoferrin or a fragment thereof inhibits the endotoxininduced interleukin-6 response in human monocytic cells
51. Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards tryptic proteolysis
52. Lactoferrin-lipopolysaccharide interactions: Effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells
53. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein
54. Lactoferrin is a lipid A-binding protein
55. Heparin-binding properties of lactoferrin and lysozyme
56. Neutralization of heparin activity by neutrophil lactoferrin
57. Characterization of the glycosaminoglycan-binding region of lactoferrin
58. Human milk lactoferrin binds two DNA molecules with different affinities
59. Rapid purification of porcine colostral whey lactoferrin by affinity chromatography on ssDNA-agarose Characterization, amino acid composition and N-terminal amino acid sequence
60. Origin of intact lactoferrin and its DNA-binding fragments found in the urine of human milk-fed preterm infants: Evaluation by stable isotopic enrichment
61. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA
62. Delineation of CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo
63. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides
64. Apolactoferrin structure demonstrates ligand-induced conformational changes in transferrins
65. Lactoferrin: The role of conformational changes in its iron binding and release
66. X-ray solution scattering reveals conformational changes upon iron uptake in lactoferrin, serum and ovo-transferrins
67. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin
68. Granulocytes of critically ill patients spontaneously express the 72 kD heat shock protein
69. Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin
70. Direct detection and quantitative determination of bovine lactoferricin and lactoferrin fragments in human gastric contents by affinity mass spectrometry
71. Inhibition of binding of lactoferrin to the human promonocyte cell line THP-1 by heparin: The role of cell surface sulphated molecules
72. Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line
73. Proteolytic processing of NFκB/IκB in human monocytes. ATP-dependent induction by proinflammatory mediators
74. Lactoferrin binds to cell membrane DNA: Association of surface DNA with an enriched population of B cells and monocytes
75. Lactoferrin binding to human peripheral blood cells: Interaction with a B-enriched population of lymphocytes and a subpopulation of adherent mononuclear cells
76. Human leukocyte elastase, cathepsin G, and lactoferrin: Family of neutrophil granule glycoproteins that bind to an alveolar macrophage receptor
77. Visualization of lactotransferrin brush-border receptors by ligand-blotting
78. The N-terminal domain I of human lactotransferrin binds specifically to phytohemagglutinin-stimulated peripheral blood human lymphocyte receptors
79. Isolated rat hepatocytes bind lactoferrins by the RHL-1 subunit of the asialoglycoprotein receptor in a galactose-independent manner
80. Iron loading of isolated rat hepatocytes inhibits asialoglycoprotein receptor dynamics and induces formation of rat hepatic leptin-1 (RHL-1) oligomers
81. Hepatic receptor that specifically binds oligosaccharides containing fucosyl α1-3-N-acetylglucosamine linkages
82. Isolation and function of a receptor for human lactoferrin in human fetal intestinal brush-border membranes
83. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance
84. Role of basic residues of human lactoferrin in the interaction with B lymphocytes
85. Fate of human lactoferrin and myeloperoxidase in phagocytizing human neutrophils: Effects of immunoglobulin G subclasses and immune complexes coated on latex beads
86. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal diseasecontrol subjects
87. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease
88. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid
89. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis
90. Pathogenetic mechanisms in cystic fibrosis lung disease: A paradigm for inflammatory airways disease